S
Silo Pharma Inc
NASDAQ:SILO
Silo Pharma Inc
NASDAQ:SILO
Price:
0.509
USD
24.3%
Market Closed
Market Cap:
$7.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Silo Pharma Inc
Inventory
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Silo Pharma Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Silo Pharma Inc
NASDAQ:SILO
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PVH Corp
NYSE:PVH
|
Inventory
$1.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
Levi Strauss & Co
NYSE:LEVI
|
Inventory
$1.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Tapestry Inc
NYSE:TPR
|
Inventory
$896.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Ralph Lauren Corp
NYSE:RL
|
Inventory
$1.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
VF Corp
NYSE:VFC
|
Inventory
$1.7B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
No Stocks Found
Silo Pharma Inc
Glance View
Silo Pharma, Inc. engages in the development of streetwear apparel brands. The company is headquartered in Englewood Cliffs, New Jersey. The company went IPO on 2012-01-05. The firm is focused on merging traditional therapeutics with psychedelic research for people suffering from indications, including depression, post-traumatic stress disorder (PTSD), Parkinson's disease and other neurological disorders. The firm is focused on the use of psilocybin as a therapeutic. Psilocybin is considered a serotonergic hallucinogen and is an ingredient in some species of mushrooms.
SILO
Intrinsic Value
0.014
USD
Overvaluation 97%
S
